ReRx Therapeutics
Biotechnology Research • • 1-10 Employees
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
Key Contact at ReRx Therapeutics
Anders Naar
Co-Founder and Chief Innovation Officer
ReRx Therapeutics Email Formats
ReRx Therapeutics uses 1 email format. The most common is {first name} (e.g., john@rerxtherapeutics.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@rerxtherapeutics.com | 100% |
About ReRx Therapeutics
ReRx is developing novel, oral therapeutics to treat patients with severe metabolic diseases including obesity, metabolic syndrome, diabetes, and liver diseases. Our therapeutics target metabolic pathways involved in regulating energy homeostasis and improve treatment outcomes compared to similar pharmacological agents. ReRx is part of the Berkeley SkyDeck Cohort 17 (https://skydeck.berkeley.edu).
ReRx Therapeutics revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
ReRx Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
ReRx Therapeutics has never raised funding before.
ReRx Therapeutics Tech Stack
Discover the technologies and tools that power ReRx Therapeutics's digital infrastructure, from frameworks to analytics platforms.
CDN
CDN
JavaScript libraries
Hosting
Miscellaneous
Miscellaneous
Page builders
JavaScript libraries
Font scripts
Australia
Netherlands
Frequently asked questions
4.8
40,000 users
